Compare iShares Core MSCI EAFE ETF (IEFA) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core MSCI EAFE ETF vs Procter & Gamble Co — how do they compare? iShares Core MSCI EAFE ETF trades at $96.56 (market cap $189.19B), while Procter & Gamble Co trades at $151.23 (market cap $349.77B). The key difference: Procter & Gamble Co is the larger of the two by market cap, and Procter & Gamble Co pays a 2.89% dividend while iShares Core MSCI EAFE ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI EAFE ETF for 40 Days and Procter & Gamble Co for 131 Days on average.
| IEFA | PG | |
|---|---|---|
Market Cap | $189.19B | $349.77B |
Volume | 8,441,787 | 10,055,825 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $101.41 | $167.18 |
52-Week Low | $85.06 | $138.10 |
Typical Hold Time | 40 Days | 131 Days |
Enterprise Value | — | $375.61B |
Dividend Yield | — | 2.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IEFA, the iShares Core MSCI EAFE ETF, trades at $96.52, up 0.33% on the day, but technical indicators signal a bearish trend with moving averages and oscillators in sell territory. The ETF provides exposure to developed markets outside North America, holding $196 billion in assets under management and offering a competitive expense ratio of 0.07%. Recent financial news highlights its role in international diversification, comparing favorably to peers on dividend yield and cost efficiency.
The outlook for IEFA is tempered by near-term technical weakness and broader market shifts away from concentrated U.S. tech exposure. Key risks include geopolitical tensions and interest rate uncertainty, but its low-cost structure and focus on established economies provide a defensive tilt for long-term investors seeking international diversification amid S&P 500 concentration concerns.
Procter & Gamble (PG) trades at $150.59, up 1.87% with bullish technical momentum as it approaches resistance near $151. The company demonstrates strong fundamentals with consistent earnings beats, 18.44% net margins, and robust cash flow generation. Recent partnership with the WNBA highlights strategic brand expansion while maintaining a 69-year dividend growth streak. Valuation metrics show premium multiples relative to peers, with P/E at 22.75 and P/S at 4.19.
PG offers stable growth with dividend reliability but faces valuation concerns amid modest revenue expansion. The consensus price target of $160.13 suggests 6.3% upside potential, supported by 53 analyst ratings favoring Buy (52.8%). Key risks include premium valuation pressure and competitive market dynamics. The stock presents a defensive investment opportunity with consistent cash flow generation in consumer staples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Core MSCI EAFE ETF
IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.
Read more on IEFA →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
